Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gynecological Malignancy”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Early research (Phase 1)Study completedNCT02978755
What this trial is testing

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

Who this might be right for
Neoplasm, Gynecologic
GamaMabs Pharma 78
Not applicableStudy completedNCT02842047
What this trial is testing

The Mediating Effects of Decentering on Self-Management of Stress and End of Life Planning

Who this might be right for
Stage IV Gastrointestinal CancerAdvanced Gynecological Cancer
Case Comprehensive Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT00850772
What this trial is testing

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Queensland Centre for Gynaecological Cancer 109
Not applicableTemporarily Not AvailableNCT03842865
What this trial is testing

Expanded Access of Vigil in Solid Tumors

Who this might be right for
Solid TumorEwing SarcomaEwing's Tumor Metastatic+5 more
Gradalis, Inc.
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT01079832
What this trial is testing

Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

Who this might be right for
Fallopian Tube CancerOvarian SarcomaOvarian Stromal Cancer+23 more
Case Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06796907
What this trial is testing

GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors

Who this might be right for
Tumours, Gynecological
GlaxoSmithKline 392
Early research (Phase 1)Ended earlyNCT06130254
What this trial is testing

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Who this might be right for
Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT02172638
What this trial is testing

Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management

Who this might be right for
Median Length of StayReadmission RateSurgery Related Complications Rate+1 more
Hospital Universitari Vall d'Hebron Research Institute 110
Early research (Phase 1)Looking for participantsNCT05238922
What this trial is testing

Study of INCB123667 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 604
Not applicableActive Not RecruitingNCT05731661
What this trial is testing

Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

Who this might be right for
Long Term Cancer Side EffectsSupportive Care in CancerCancer Survivorship Care Plan+2 more
Centre Francois Baclesse 99
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Not applicableLooking for participantsNCT06232213
What this trial is testing

Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model

Who this might be right for
Personalized Cancer Treatment
Hua Li 40
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Not applicableEnded earlyNCT03993210
What this trial is testing

The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Who this might be right for
Gynecologic Tumor
Dana-Farber Cancer Institute 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07448922
What this trial is testing

SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Advanced Gynecological Malignancies
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. 290
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Early research (Phase 1)Study completedNCT02076620
What this trial is testing

L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumors Amenable to Anthracycline TherapySarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
Philogen S.p.A. 29
Not applicableLooking for participantsNCT04957511
What this trial is testing

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Who this might be right for
Gynecologic CancerImmunotherapyGut Microbiome
Viome 30
Testing effectiveness (Phase 2)Ended earlyNCT04493619
What this trial is testing

PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

Who this might be right for
Gynecologic NeoplasmsEpithelial Ovarian Cancer
Opna Bio LLC 37
Load More Results